Dr KISAKA PATRICK
@kimkis.bsky.social
Infectious Disease Specialist , expertise in HIV, TB, viral hepatitis, and epidemic response. Skilled in healthcare quality, team leadership, and system strengthening in resource-limited settings.
Médecin sans frontières
Médecin sans frontières
Reposted by Dr KISAKA PATRICK
"At a population level... addition of macrolides was not associated with improved clinical outcomes for CAP... potential advantages of combining macrolides with a β-lactam antibiotic ... should be balanced against the risks of adverse effects... & AMR." #IDSky
academic.oup.com/jid/advance-...
academic.oup.com/jid/advance-...
December 28, 2024 at 5:30 PM
"At a population level... addition of macrolides was not associated with improved clinical outcomes for CAP... potential advantages of combining macrolides with a β-lactam antibiotic ... should be balanced against the risks of adverse effects... & AMR." #IDSky
academic.oup.com/jid/advance-...
academic.oup.com/jid/advance-...
I’ve just joined Bluesky to connect with a broader community and share insights on infectious diseases, global health, and beyond.
Looking forward to engaging with you all!
#NewToBluesky #InfectiousDiseases #GlobalHealth
Looking forward to engaging with you all!
#NewToBluesky #InfectiousDiseases #GlobalHealth
November 21, 2024 at 7:28 AM
I’ve just joined Bluesky to connect with a broader community and share insights on infectious diseases, global health, and beyond.
Looking forward to engaging with you all!
#NewToBluesky #InfectiousDiseases #GlobalHealth
Looking forward to engaging with you all!
#NewToBluesky #InfectiousDiseases #GlobalHealth
Reposted by Dr KISAKA PATRICK
No one follow him. Please.
November 18, 2024 at 4:35 AM
No one follow him. Please.